Hemel Hempstead, United Kingdom - June 22, 2012, Hemel Hempstead, United Kingdom - Consort Medical plc announced the appointment of Steve Crummett and Ian Nicholson as non-executive directors, effective immediately, and Richard Cotton as group finance director and executive director, with effect from June 25, 2012.
Article continues below
Steve Crummett is Group Finance Director of Filtrona plc, a FTSE 250 company, having been appointed to the role in 2008. From 2003 to 2006, Mr. Crummett was Group Director, Mergers & Acquisitions of the FTSE 100 company Exel plc. Steve qualified as a Chartered Accountant with Arthur Andersen. Mr. Crummett will Chair the Audit Committee, and join the Nomination Committee.
Ian Nicholson has been Chief Executive of Chroma Therapeutics Limited, a drug discovery and development company since 2004. He is Chairman of Bioventix Ltd, a diagnostics company, and a Non-executive Director of Symphogen A/S, an antibody therapeutics company.
From 2000 to 2004 Mr. Nicholson was Senior Vice President, Business Development at Celltech Group plc, then the UK's largest biotechnology company. He has extensive experience in licensing, mergers and acquisitions, and market development in the UK, Europe and the US. Mr. Nicholson will join the Nomination Committee.
Richard Cotton, a Chartered Management Accountant, has been appointed Group Finance Director of Consort Medical with effect from 25 June 2012.
From 2008 to 2011 he was Group Finance Director of Vitec Group plc, from 2005 to 2008 Group Finance Director at Wagon plc (Wagon plc entered administration on 10th December 2008), and from 2001 to 2005 Group Finance Director of McLeod Russell plc.
The company also announced the retirement of Chris Banks and Jim Dick as Non-executive Directors, effective August 30, 2012. Toby Woolrych, currently Group Finance Director, has decided to leave the Company, and will step down on June 29, 2012.
Mr. Banks was appointed as a non-executive director in April 2006. He was Finance Director at The BIS Group from 1985 to 1991 and at CMG plc from 1992 to 2000. He is currently chairman of the Audit Committee and Senior Independent Director of The Innovation Group plc and a trustee of The Barbara Ward Children's Foundation. Mr. Banks is a chartered accountant and a member of the Association of Corporate Treasurers. He chairs the Audit Committee and is a member of the Nomination Committee.
Mr. Dick was appointed as a non-executive director in April 2006 having served as President of Smith & Nephew plc's Wound Management division since 1999. He is Chairman of Cat.Zero, a not for profit organisation. He is a member of the Council of the University of Hull, Yorkshire Innovation and the Management Board of the HullYork Medical School and he also consults for Private Equity. Mr. Dick is chairman of the CSR Committee and a member of the Remuneration, Audit and Nomination Committees. ■